Nano-Hydroxyapatite Stimulation of Gene Expression Requires Fgf Receptor, Phosphate Transporter, and Erk1/2 Signaling
Source abstract
Abstract
Hydroxyapatite (HAp) is critical to health both as the main structural material of the skeleton and storage material of calcium and phosphate. Nanosized HAp (nHAp) is naturally produced by mineralizing cells during bone formation and remodeling and is the main constituent of the skeleton. As such, HAp is currently being investigated as a therapeutic biomaterial for orthopedic and dental purposes. Recent studies have suggested that extracellular nHAp can influence osteoblast lineage commitment and cell function through changes in gene expression; however, the mechanisms remain to be elucidated. Here, the cellular and molecular mechanism by which rod-shaped nHAp (10 × 100 nm) stimulates gene expression in preosteoblast bone marrow stromal cells was investigated. Electron microscopy detected a rapid and stable interaction of nHAp with the cell membrane, which correlated with a strong stimulation of the Erk1/2 signaling pathway. Results also identified the requirement of the Fgf receptor signaling and phosphate-transporters for nHAp regulated gene expression whereas a calcium-sensing receptor inhibitor had no effect. Collectively, the study uncovers novel signaling pathways and cellular events specifically stimulated by and required for the cellular response to free extracellular HAp. The results provide insight into the osteoblastic response to HAp relevant to functional mineralization and pathological calcification and could be used in the development of biomaterials for orthopedic purposes.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Parathyroid Disorders and Treatments · Bone health and osteoporosis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Medicine, Division of Endocrinology, Emory University, 101 Woodruff Circle, 1026 WMRB, Atlanta, Georgia 30322, United States
The Atlanta Department of Veterans Affairs Medical Center, Decatur, Georgia 30033, United States
The Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, United States
Funding
National Center for Advancing Translational Sciences · U.S. Department of Veterans Affairs · Emory University
References (70)
Show source-provided references
1. 10.1074/jbc.272.7.440410.1074/jbc.272.7.4404 ↗
2. 10.1038/nmat362710.1038/nmat3627 ↗
3. 10.1097/01.ASN.0000141960.01035.2810.1097/01.ASN.0000141960.01035.28 ↗
4. 10.1159/00033595210.1159/000335952 ↗
5. 10.1152/ajpcell.00229.201010.1152/ajpcell.00229.2010 ↗
6. 10.2147/IJN.S6318910.2147/IJN.S63189 ↗
7. 10.1038/ki.2012.48210.1038/ki.2012.482 ↗
8. 10.1161/CIRCRESAHA.110.23491410.1161/CIRCRESAHA.110.234914 ↗
9. 10.1021/bi962686710.1021/bi9626867 ↗
10. 10.1016/j.rmed.2014.01.01210.1016/j.rmed.2014.01.012 ↗
11. Stein G. S. · FASEB J. · 1990 · 4 · 311110.1096/fasebj.4.13.2210157 ↗
12. 10.2741/157610.2741/1576 ↗
13. 10.1097/00003086-197107000-0001010.1097/00003086-197107000-00010 ↗
14. 10.2217/17435889.1.2.16910.2217/17435889.1.2.169 ↗
15. 10.1089/ten.teb.2012.062410.1089/ten.teb.2012.0624 ↗
16. 10.1016/j.biomaterials.2005.12.00810.1016/j.biomaterials.2005.12.008 ↗
17. 10.1155/2014/17130510.1155/2014/171305 ↗
18. 10.1186/1471-2474-15-11410.1186/1471-2474-15-114 ↗
19. 10.1016/j.ijbiomac.2010.03.01510.1016/j.ijbiomac.2010.03.015 ↗
20. 10.1039/b705129h10.1039/b705129h ↗
21. 10.1016/j.colsurfb.2014.02.00410.1016/j.colsurfb.2014.02.004 ↗
22. 10.1002/jat.174510.1002/jat.1745 ↗
23. 10.1098/rsif.2014.000410.1098/rsif.2014.0004 ↗
24. 10.1016/j.biomaterials.2009.07.00210.1016/j.biomaterials.2009.07.002 ↗
25. 10.1039/c2nr00044j10.1039/c2nr00044j ↗
26. 10.1007/s10856-012-4703-610.1007/s10856-012-4703-6 ↗
27. 10.1016/j.actbio.2008.07.02310.1016/j.actbio.2008.07.023 ↗
28. 10.1016/j.biomaterials.2015.06.03910.1016/j.biomaterials.2015.06.039 ↗
29. 10.1055/s-2003-4322910.1055/s-2003-43229 ↗
30. 10.1681/ASN.200607077110.1681/ASN.2006070771 ↗
31. 10.1002/jcp.2431210.1002/jcp.24312 ↗
32. 10.1083/jcb.96.1.19110.1083/jcb.96.1.191 ↗
33. 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A ↗
34. 10.1016/j.nano.2011.11.00310.1016/j.nano.2011.11.003 ↗
35. 10.1002/jbm.a.3442610.1002/jbm.a.34426 ↗
36. 10.1038/nrendo.2015.3010.1038/nrendo.2015.30 ↗
37. Werner A. · J. Exp. Biol. · 1998 · 201 · 313510.1242/jeb.201.23.3135 ↗
38. 10.1146/annurev-physiol-030212-18374810.1146/annurev-physiol-030212-183748 ↗
39. 10.1074/jbc.M30447020010.1074/jbc.M304470200 ↗
40. 10.2147/IJN.S2659210.2147/IJN.S26592 ↗
41. 10.1016/j.jconrel.2010.01.03610.1016/j.jconrel.2010.01.036 ↗
42. 10.1083/jcb.111.6.293110.1083/jcb.111.6.2931 ↗
43. 10.1002/jbm.a.3003510.1002/jbm.a.30035 ↗
44. 10.1186/1471-2474-7-5010.1186/1471-2474-7-50 ↗
45. 10.1089/ten.teb.2013.022110.1089/ten.teb.2013.0221 ↗
46. 10.1016/j.jsb.2008.03.00310.1016/j.jsb.2008.03.003 ↗
47. 10.1038/nmat451910.1038/nmat4519 ↗
48. 10.1016/j.bone.2016.04.00710.1016/j.bone.2016.04.007 ↗
49. 10.1161/CIRCRESAHA.110.23880810.1161/CIRCRESAHA.110.238808 ↗
50. 10.1161/CIRCRESAHA.108.18130510.1161/CIRCRESAHA.108.181305 ↗
51. 10.1088/0957-4484/22/10/10570810.1088/0957-4484/22/10/105708 ↗
52. 10.1111/j.1600-0854.2012.01395.x10.1111/j.1600-0854.2012.01395.x ↗
53. Szczepanska-Konkel M. · J. Biol. Chem. · 1986 · 261 · 637510.1016/S0021-9258(19)84572-6 ↗
54. 10.1016/j.jsbmb.2006.12.09010.1016/j.jsbmb.2006.12.090 ↗
55. 10.1128/MCB.00104-0710.1128/MCB.00104-07 ↗
56. 10.1007/s00223-011-9506-010.1007/s00223-011-9506-0 ↗
57. 10.1371/journal.pone.005339310.1371/journal.pone.0053393 ↗
58. 10.1161/01.RES.0000216409.20863.e710.1161/01.RES.0000216409.20863.e7 ↗
59. 10.1038/sj.onc.120640610.1038/sj.onc.1206406 ↗
60. 10.1073/pnas.132171711110.1073/pnas.1321717111 ↗
61. 10.1007/s12031-016-0778-810.1007/s12031-016-0778-8 ↗
62. 10.1083/jcb.20061004610.1083/jcb.200610046 ↗
63. 10.1016/j.msec.2014.04.04210.1016/j.msec.2014.04.042 ↗
64. 10.1016/j.tiv.2013.12.00110.1016/j.tiv.2013.12.001 ↗
65. 10.1016/S0014-4827(03)00213-110.1016/S0014-4827(03)00213-1 ↗
66. 10.1038/ki.2010.39010.1038/ki.2010.390 ↗
67. 10.1096/fj.14-26551210.1096/fj.14-265512 ↗
68. 10.1002/jbmr.234110.1002/jbmr.2341 ↗
69. 10.1002/jcb.1062210.1002/jcb.10622 ↗
70. 10.1002/jbm.a.3014010.1002/jbm.a.30140 ↗